Event-Free Survival Extended With Long-Term Finerenone in Heart Failure
Long-term finerenone extends event-free survival up to three years for heart failure with mildly reduced or preserved ejection fraction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.